- Home
- NRXS vs NAII Comparison
NRXS vs NAII Comparison
Compare NRXS & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- NAII
- Stock Information
- Founded
- NRXS 2011
- NAII 1980
- Country
- NRXS United States
- NAII United States
- Employees
- NRXS N/A
- NAII N/A
- Industry
- NRXS
- NAII Medicinal Chemicals and Botanical Products
- Sector
- NRXS
- NAII Health Care
- Exchange
- NRXS Nasdaq
- NAII Nasdaq
- Market Cap
- NRXS 25.8M
- NAII 21.2M
- IPO Year
- NRXS 2023
- NAII 1987
- Fundamental
- Price
- NRXS $2.75
- NAII $2.73
- Analyst Decision
- NRXS Strong Buy
- NAII
- Analyst Count
- NRXS 1
- NAII 0
- Target Price
- NRXS $7.00
- NAII N/A
- AVG Volume (30 Days)
- NRXS 1.1M
- NAII 26.5K
- Earning Date
- NRXS 11-12-2025
- NAII 11-11-2025
- Dividend Yield
- NRXS N/A
- NAII N/A
- EPS Growth
- NRXS N/A
- NAII N/A
- EPS
- NRXS N/A
- NAII N/A
- Revenue
- NRXS $3,217,531.00
- NAII $129,860,000.00
- Revenue This Year
- NRXS $62.14
- NAII N/A
- Revenue Next Year
- NRXS $131.87
- NAII N/A
- P/E Ratio
- NRXS N/A
- NAII N/A
- Revenue Growth
- NRXS 41.93
- NAII 14.12
- 52 Week Low
- NRXS $1.33
- NAII $2.57
- 52 Week High
- NRXS $6.20
- NAII $4.81
- Technical
- Relative Strength Index (RSI)
- NRXS 39.71
- NAII 44.79
- Support Level
- NRXS $2.94
- NAII $2.70
- Resistance Level
- NRXS $3.96
- NAII $3.00
- Average True Range (ATR)
- NRXS 0.34
- NAII 0.17
- MACD
- NRXS -0.11
- NAII 0.03
- Stochastic Oscillator
- NRXS 3.10
- NAII 28.57
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.